- Intended Audience: Pharmacists interested in precision medicine.
- UAN: 0012-0000-17-316-H04-P
- CE Hours: 1.5 General
- Price: $15.00
- Dates Available: 01/01/2018-01/01/2021
- Activity Type: Knowledge
This course will summarize pharmacogenomics in oncology, adverse reactions, and electronic health records.
Clinical Applications in Oncology Pharmacogenetics
- Describe clinical implications of genetic variability in oncology pharmacotherapy.
- Discuss clinical, patient-specific, genetic, and other factors that inform drug therapy changes in oncology.
- Summarize the structure and characteristics of representative oncology pharmacogenetics implementations.
Clinical Applications of Pharmacogenetics in Hypersensitivity/Adverse Drug Reactions
- Discuss the mechanism of drug-induced hypersensitivity.
- Summarize the evidence and discuss clinical implications for the association of HLA-B and HLA-A with carbamazepine-induced hypersensitivty reactions.
- Summarize the evidence and discuss clinical implications for the association of HLA-B with abacavir-induced hypersensitive reactions.
- Summarize the evidence and discuss clinical implications for the association of HLA-B with allopurinol-induced hypersensitive reactions.
The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
Kristine R. Crews, Pharm. D.
Translational Research Laboratory Director
Co-director, Pharmacokinetics Shared Resource
Director, PGY2 Pharmacogenetics Residency Program
J. Kevin Hicks, Pharm.D, Ph.D.
Personalized Medicine Specialist, Department of Individualized Cancer Management
Moffitt Cancer Center
Assistant Professor, Morsani College of Medicine
University of South Florida
Schedule of Activities
Review all course materials and pass post-test with 70% or more.
View recorded lectures, receive a 70% or higher on final exam and complete course evaluation.
- The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
- All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
- It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
- The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.
This course received no outside funding support.
Computer and Internet access are required to complete this course. Course content is provided via Canvas.
This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.